Your source for the latest medtech news from AdvaMed® and our members.
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker following confirmation of Alex Azar as Secretary of the Department of…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the passage of the current continuing resolution, which includes a…
GENEVA, SWITZERLAND – On January 18, the AMR Industry Alliance launched its first report that shows the commitment of the life sciences industry to tackle the public health threat of…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the proposed continuing resolution in the U.S. House:
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement today on CMS guidance regarding Medicare Prescription Drug Part D coverage…